Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1A1P12 is a processed pseudogene related to the EEF1A1 gene, which encodes a core protein in the translation elongation machinery responsible for delivering aminoacyl-tRNAs to the ribosome during protein synthesis. Unlike its parent gene, EEF1A1P12 does not encode a functional protein, but has been reported in genomic studies through copy number variation or aberrant transcription associated with several cancer types and epilepsy, though its functional relevance remains uncertain. Pseudogenes can sometimes affect cellular processes through RNA transcripts, but EEF1A1P12 is primarily catalogued as a non-coding genomic element. It is not considered a pharmacological or therapeutic target[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 12 (EEF1A1P12).